← back to search

Mark K. Buyyounouski

Palo Alto University · US
Area of research
Pulmonary and Respiratory Medicine · Radiation
Research interest
Research interests include Prostate Cancer Diagnosis and Treatment, Prostate Cancer Treatment and Research, Advanced Radiotherapy Techniques, and Effects of Radiation Exposure.
h-index
48
citations
9,421
works
296
NIH funding
primary concept
email

Recent publications

Second-Line Radiation Therapy for Locally Recurrent Prostate Cancer After Focal Therapy: A Single Institution Matched-Pair Analysis
Clinical Genitourinary Cancer 2026cited by 0position: lastdoi
Bladder Cancer, Version 3.2024
Journal of the National Comprehensive Cancer Network 2024cited by 220position: middledoi
Salvage prostate brachytherapy in radiorecurrent prostate cancer: An international Delphi consensus study
Radiotherapy and Oncology 2023cited by 25position: middledoi
NCCN Guidelines® Insights: Bladder Cancer, Version 2.2022
Journal of the National Comprehensive Cancer Network 2022cited by 298position: middledoi
Long-Term Results of a Phase 3 Randomized Prospective Trial of Erectile Tissue-Sparing Intensity-Modulated Radiation Therapy for Men With Clinically Localized Prostate Cancer
International Journal of Radiation Oncology*Biology*Physics 2022cited by 16position: middledoi
Patient-Level Clinical Expertise Enhances Prostate Cancer Recurrence Predictions with Machine Learning
2022cited by 4position: contributordoi
A personalized decision aid for prostate cancer shared decision making
BMC Medical Informatics and Decision Making 2021cited by 20position: lastdoi
Automated Contour Propagation of the Prostate From pCT to CBCT Images via Deep Unsupervised Learning
International Journal of Radiation Oncology*Biology*Physics 2021cited by 0position: middledoi
Bladder Cancer, Version 1.2026, NCCN Clinical Practice Guidelines In Oncology
Journal of the National Comprehensive Cancer Network 2020cited by 627position: middledoi
NRG Oncology Updated International Consensus Atlas on Pelvic Lymph Node Volumes for Intact and Postoperative Prostate Cancer
International Journal of Radiation Oncology*Biology*Physics 2020cited by 138position: middledoi
Dose–response with stereotactic body radiotherapy for prostate cancer: A multi-institutional analysis of prostate-specific antigen kinetics and biochemical control
Radiotherapy and Oncology 2020cited by 33position: middledoi
Long-term Outcomes of Stereotactic Body Radiotherapy for Low-Risk and Intermediate-Risk Prostate Cancer
JAMA Network Open 2019cited by 310position: middledoi
NCCN Guidelines Insights: Bladder Cancer, Version 5.2018
Journal of the National Comprehensive Cancer Network 2018cited by 217position: middledoi
Visualizing the Invisible in Prostate Radiation Therapy: Markerless Prostate Target Localization Via a Deep Learning Model and Monoscopic Kv Projection X-Ray Image
International Journal of Radiation Oncology*Biology*Physics 2018cited by 8position: middledoi
Long-Term Outcomes of Stereotactic Body Radiation Therapy for Low and Intermediate-Risk Prostate Adenocarcinoma: A Multi-Institutional Consortium Study
International Journal of Radiation Oncology*Biology*Physics 2018cited by 4position: middledoi
Automatic Prostate Segmentation using Deep Learning and MR Images
International Journal of Radiation Oncology*Biology*Physics 2018cited by 1position: middledoi
Prostate Cancer Staging and Radiation Treatment Planning Using Deep Learning on MRI
International Journal of Radiation Oncology*Biology*Physics 2018cited by 0position: middledoi
Bladder Cancer, Version 5.2017, NCCN Clinical Practice Guidelines in Oncology
Journal of the National Comprehensive Cancer Network 2017cited by 279position: middledoi
Tadalafil for Prevention of Erectile Dysfunction After Radiotherapy for Prostate Cancer
JAMA 2014cited by 62position: middledoi
Reply to M.J. Brenner et al and I.R. Vogelius et al
Journal of Clinical Oncology 2014cited by 2position: lastdoi
High Precision Focal Brachytherapy of Prostate Cancer Guided by Dual-Mode Photoacoustic and Ultrasound Imaging
International Journal of Radiation Oncology*Biology*Physics 2014cited by 0position: middledoi
Randomized Trial of Hypofractionated External-Beam Radiotherapy for Prostate Cancer
Journal of Clinical Oncology 2013cited by 466position: lastdoi
A Novel Method for Predicting Late Genitourinary Toxicity After Prostate Radiation Therapy and the Need for Age-Based Risk-Adapted Dose Constraints
International Journal of Radiation Oncology*Biology*Physics 2013cited by 28position: lastdoi

Grants

No grants ingested yet.

Frequent collaborators

H.P. Bagshaw · Palo Alto University6 papers (2018–2021)Alan Pollack · University of Miami5 papers (2013–2022)Eric M. Horwitz · Temple University Health System4 papers (2013–2022)Richard E. Greenberg · Fox Chase Cancer Center4 papers (2013–2022)Robert G. Uzzo · Case Comprehensive Cancer Center3 papers (2013–2022)R Price · Fox Chase Cancer Center3 papers (2013–2022)S.L. Hancock · Palo Alto University3 papers (2018–2018)Radka Stoyanova · University of Miami3 papers (2013–2021)Steven J. Feigenberg · University of Pennsylvania2 papers (2013–2014)Amar U. Kishan · University of Colorado Denver2 papers (2018–2021)Wei Zhao · Palo Alto University2 papers (2018–2021)Charlie Ma · Fox Chase Cancer Center2 papers (2013–2014)Gail Walker · University of Miami2 papers (2013–2014)Benjamin Movsas · Michigan United2 papers (2013–2014)Deborah Watkins Bruner · Emory University2 papers (2014–2022)André Konski · Philadelphia University2 papers (2013–2014)Thomas M. Pisansky · Indiana University – Purdue University Indianapolis2 papers (2014–2020)Seth A. Rosenthal · Tufts University2 papers (2014–2020)Caressa Hui · Palo Alto University1 papers (2026–2026)David P. Dearnaley · Royal Marsden NHS Foundation Trust1 papers (2020–2020)